CymaBay Therapeutics

$0.00 (0.00%) As of 11:02 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBAY and other ETFs, options, and stocks.

About CBAY

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001.

CEO
Sujal Shah
Employees
59
Headquarters
Newark, California
Founded
1988

CBAY Key Statistics

Market cap
234.56M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.67M
High today
$2.97
Low today
$2.77
Open price
$2.94
Volume
386.32K
52 Week high
$4.74
52 Week low
$1.67

CBAY Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure